Cytomx Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytomx Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $890k | 189k | 4.70 |
| 2021-09-30 | $328k | 64k | 5.09 |
| 2021-06-30 | $411k | 65k | 6.33 |
| 2021-03-31 | $229k | 30k | 7.73 |
| 2020-12-31 | $323k | 49k | 6.55 |
| 2020-09-30 | $328k | 49k | 6.65 |
| 2020-06-30 | $258k | 31k | 8.33 |
| 2020-03-31 | $210k | 27k | 7.67 |
| 2019-12-31 | $287k | 35k | 8.31 |
| 2019-09-30 | $274k | 37k | 7.38 |
| 2019-06-30 | $321k | 29k | 11.22 |
| 2019-03-31 | $264k | 25k | 10.75 |
| 2018-12-31 | $196k | 13k | 15.10 |
| 2018-09-30 | $241k | 13k | 18.50 |
| 2018-06-30 | $277k | 12k | 22.86 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas